Anchor Investment Management’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $21 | Hold |
12
| – | – | ﹤0.01% | 1043 |
|
2025
Q1 | $20 | Hold |
12
| – | – | ﹤0.01% | 1038 |
|
2024
Q4 | $27 | Hold |
12
| – | – | ﹤0.01% | 1020 |
|
2024
Q3 | $32 | Hold |
12
| – | – | ﹤0.01% | 1044 |
|
2024
Q2 | $38 | Hold |
12
| – | – | ﹤0.01% | 994 |
|
2024
Q1 | $31 | Hold |
12
| – | – | ﹤0.01% | 1029 |
|
2023
Q4 | $74 | Hold |
12
| – | – | ﹤0.01% | 949 |
|
2023
Q3 | $83 | Hold |
12
| – | – | ﹤0.01% | 967 |
|
2023
Q2 | $110 | Hold |
12
| – | – | ﹤0.01% | 954 |
|
2023
Q1 | $19 | Hold |
12
| – | – | ﹤0.01% | 977 |
|
2022
Q4 | $19 | Hold |
12
| – | – | ﹤0.01% | 947 |
|
2022
Q3 | $111 | Hold |
12
| – | – | ﹤0.01% | 970 |
|
2022
Q2 | $40 | Sell |
12
-1
| -8% | -$3 | ﹤0.01% | 963 |
|
2022
Q1 | $83 | Hold |
13
| – | – | ﹤0.01% | 980 |
|
2021
Q4 | $80 | Hold |
13
| – | – | ﹤0.01% | 994 |
|
2021
Q3 | $174 | Hold |
13
| – | – | ﹤0.01% | 925 |
|
2021
Q2 | $232 | Hold |
13
| – | – | ﹤0.01% | 940 |
|
2021
Q1 | $292 | Hold |
13
| – | – | ﹤0.01% | 941 |
|
2020
Q4 | $234 | Hold |
13
| – | – | ﹤0.01% | 903 |
|
2020
Q3 | $318 | Hold |
13
| – | – | ﹤0.01% | 879 |
|
2020
Q2 | $361 | Hold |
13
| – | – | ﹤0.01% | 857 |
|
2020
Q1 | $602 | Hold |
13
| – | – | ﹤0.01% | 834 |
|
2019
Q4 | $711 | Hold |
13
| – | – | ﹤0.01% | 810 |
|
2019
Q3 | $775 | Hold |
13
| – | – | ﹤0.01% | 787 |
|
2019
Q2 | $563 | Hold |
13
| – | – | ﹤0.01% | 789 |
|
2019
Q1 | $786 | Hold |
13
| – | – | ﹤0.01% | 774 |
|
2018
Q4 | $674 | Hold |
13
| – | – | ﹤0.01% | 794 |
|
2018
Q3 | $1.26K | Buy |
+13
| New | +$1.26K | ﹤0.01% | 790 |
|